Antibody Drug Conjugate Drug Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mmunomedics Technology
1.2.3 Immunogen Technology
1.2.4 Seattle Genetics Technology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biotechnology Companies
1.3.3 Specialized Cancer Centers
1.3.4 Biopharmaceutical Companies
1.3.5 Academic Research Institutes
1.3.6 Hospitals
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antibody Drug Conjugate (ADC) Drug Market Perspective (2017-2028)
2.2 Antibody Drug Conjugate (ADC) Drug Growth Trends by Region
2.2.1 Antibody Drug Conjugate (ADC) Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antibody Drug Conjugate (ADC) Drug Historic Market Size by Region (2017-2022)
2.2.3 Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Region (2023-2028)
2.3 Antibody Drug Conjugate (ADC) Drug Market Dynamics
2.3.1 Antibody Drug Conjugate (ADC) Drug Industry Trends
2.3.2 Antibody Drug Conjugate (ADC) Drug Market Drivers
2.3.3 Antibody Drug Conjugate (ADC) Drug Market Challenges
2.3.4 Antibody Drug Conjugate (ADC) Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Revenue
3.1.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Revenue (2017-2022)
3.1.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2017-2022)
3.2 Global Antibody Drug Conjugate (ADC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Drug Conjugate (ADC) Drug Revenue
3.4 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio
3.4.1 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate (ADC) Drug Revenue in 2021
3.5 Antibody Drug Conjugate (ADC) Drug Key Players Head office and Area Served
3.6 Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
3.7 Date of Enter into Antibody Drug Conjugate (ADC) Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug Conjugate (ADC) Drug Breakdown Data by Type
4.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Type (2017-2022)
4.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Type (2023-2028)
5 Antibody Drug Conjugate (ADC) Drug Breakdown Data by Application
5.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Application (2017-2022)
5.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
6.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Type
6.2.1 North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
6.2.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
6.2.3 North America Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
6.3 North America Antibody Drug Conjugate (ADC) Drug Market Size by Application
6.3.1 North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
6.3.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
6.3.3 North America Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
6.4 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country
6.4.1 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
6.4.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type
7.2.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
7.2.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
7.2.3 Europe Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application
7.3.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
7.3.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
7.3.3 Europe Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
7.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country
7.4.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
7.4.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
8.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type
8.2.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application
8.3.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region
8.4.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
9.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type
9.2.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
9.2.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
9.2.3 Latin America Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
9.3 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application
9.3.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
9.3.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
9.3.3 Latin America Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
9.4 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country
9.4.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
9.4.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
10.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type
10.2.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application
10.3.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country
10.4.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Oxford Bio Therapeutics
11.1.1 Oxford Bio Therapeutics Company Details
11.1.2 Oxford Bio Therapeutics Business Overview
11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.1.4 Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.1.5 Oxford Bio Therapeutics Recent Developments
11.2 Synthon
11.2.1 Synthon Company Details
11.2.2 Synthon Business Overview
11.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Introduction
11.2.4 Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.2.5 Synthon Recent Developments
11.3 Progenics Pharmaceuticals
11.3.1 Progenics Pharmaceuticals Company Details
11.3.2 Progenics Pharmaceuticals Business Overview
11.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
11.3.4 Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.3.5 Progenics Pharmaceuticals Recent Developments
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Details
11.4.2 Bayer HealthCare Business Overview
11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Introduction
11.4.4 Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.4.5 Bayer HealthCare Recent Developments
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Details
11.5.2 Millennium Pharmaceuticals Business Overview
11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
11.5.4 Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.5.5 Millennium Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Introduction
11.6.4 Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Concortis Bio therapeutics
11.7.1 Concortis Bio therapeutics Company Details
11.7.2 Concortis Bio therapeutics Business Overview
11.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.7.4 Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.7.5 Concortis Bio therapeutics Recent Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Details
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Introduction
11.8.4 Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.8.5 Roche Holding AG Recent Developments
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Details
11.9.2 Seattle Genetics Business Overview
11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Introduction
11.9.4 Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.9.5 Seattle Genetics Recent Developments
11.10 Heidelberg Pharma
11.10.1 Heidelberg Pharma Company Details
11.10.2 Heidelberg Pharma Business Overview
11.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Introduction
11.10.4 Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.10.5 Heidelberg Pharma Recent Developments
11.11 Mersana Therapeutics
11.11.1 Mersana Therapeutics Company Details
11.11.2 Mersana Therapeutics Business Overview
11.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.11.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.11.5 Mersana Therapeutics Recent Developments
11.12 Astellas Pharma/Agensys
11.12.1 Astellas Pharma/Agensys Company Details
11.12.2 Astellas Pharma/Agensys Business Overview
11.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Introduction
11.12.4 Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.12.5 Astellas Pharma/Agensys Recent Developments
11.13 AbbVie Inc
11.13.1 AbbVie Inc Company Details
11.13.2 AbbVie Inc Business Overview
11.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Introduction
11.13.4 AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.13.5 AbbVie Inc Recent Developments
11.14 Celldex Therapeutics
11.14.1 Celldex Therapeutics Company Details
11.14.2 Celldex Therapeutics Business Overview
11.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.14.4 Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.14.5 Celldex Therapeutics Recent Developments
11.15 Immunomedics
11.15.1 Immunomedics Company Details
11.15.2 Immunomedics Business Overview
11.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Introduction
11.15.4 Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.15.5 Immunomedics Recent Developments
11.16 Agensys
11.16.1 Agensys Company Details
11.16.2 Agensys Business Overview
11.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Introduction
11.16.4 Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.16.5 Agensys Recent Developments
11.17 Genentech
11.17.1 Genentech Company Details
11.17.2 Genentech Business Overview
11.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Introduction
11.17.4 Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.17.5 Genentech Recent Developments
11.18 ImmunoGen
11.18.1 ImmunoGen Company Details
11.18.2 ImmunoGen Business Overview
11.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Introduction
11.18.4 ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.18.5 ImmunoGen Recent Developments
11.19 Sanofi
11.19.1 Sanofi Company Details
11.19.2 Sanofi Business Overview
11.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Introduction
11.19.4 Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.19.5 Sanofi Recent Developments
11.20 Genmab
11.20.1 Genmab Company Details
11.20.2 Genmab Business Overview
11.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Introduction
11.20.4 Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.20.5 Genmab Recent Developments
11.21 Amgen
11.21.1 Amgen Company Details
11.21.2 Amgen Business Overview
11.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Introduction
11.21.4 Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.21.5 Amgen Recent Developments
11.22 Novartis
11.22.1 Novartis Company Details
11.22.2 Novartis Business Overview
11.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Introduction
11.22.4 Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.22.5 Novartis Recent Developments
11.23 Eli Lilly
11.23.1 Eli Lilly Company Details
11.23.2 Eli Lilly Business Overview
11.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Introduction
11.23.4 Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.23.5 Eli Lilly Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Mmunomedics Technology
Table 3. Key Players of Immunogen Technology
Table 4. Key Players of Seattle Genetics Technology
Table 5. Key Players of Others
Table 6. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Antibody Drug Conjugate (ADC) Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Antibody Drug Conjugate (ADC) Drug Market Share by Region (2017-2022)
Table 10. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Antibody Drug Conjugate (ADC) Drug Market Share by Region (2023-2028)
Table 12. Antibody Drug Conjugate (ADC) Drug Market Trends
Table 13. Antibody Drug Conjugate (ADC) Drug Market Drivers
Table 14. Antibody Drug Conjugate (ADC) Drug Market Challenges
Table 15. Antibody Drug Conjugate (ADC) Drug Market Restraints
Table 16. Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Players (2017-2022)
Table 18. Global Top Antibody Drug Conjugate (ADC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate (ADC) Drug as of 2021)
Table 19. Ranking of Global Top Antibody Drug Conjugate (ADC) Drug Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Antibody Drug Conjugate (ADC) Drug Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
Table 23. Date of Enter into Antibody Drug Conjugate (ADC) Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type (2017-2022)
Table 27. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type (2023-2028)
Table 29. Global Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Application (2017-2022)
Table 31. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Application (2023-2028)
Table 33. North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 63. Oxford Bio Therapeutics Company Details
Table 64. Oxford Bio Therapeutics Business Overview
Table 65. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 66. Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 67. Oxford Bio Therapeutics Recent Developments
Table 68. Synthon Company Details
Table 69. Synthon Business Overview
Table 70. Synthon Antibody Drug Conjugate (ADC) Drug Product
Table 71. Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 72. Synthon Recent Developments
Table 73. Progenics Pharmaceuticals Company Details
Table 74. Progenics Pharmaceuticals Business Overview
Table 75. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product
Table 76. Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 77. Progenics Pharmaceuticals Recent Developments
Table 78. Bayer HealthCare Company Details
Table 79. Bayer HealthCare Business Overview
Table 80. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product
Table 81. Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 82. Bayer HealthCare Recent Developments
Table 83. Millennium Pharmaceuticals Company Details
Table 84. Millennium Pharmaceuticals Business Overview
Table 85. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product
Table 86. Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 87. Millennium Pharmaceuticals Recent Developments
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Antibody Drug Conjugate (ADC) Drug Product
Table 91. Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 92. Pfizer Recent Developments
Table 93. Concortis Bio therapeutics Company Details
Table 94. Concortis Bio therapeutics Business Overview
Table 95. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 96. Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 97. Concortis Bio therapeutics Recent Developments
Table 98. Roche Holding AG Company Details
Table 99. Roche Holding AG Business Overview
Table 100. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product
Table 101. Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 102. Roche Holding AG Recent Developments
Table 103. Seattle Genetics Company Details
Table 104. Seattle Genetics Business Overview
Table 105. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product
Table 106. Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 107. Seattle Genetics Recent Developments
Table 108. Heidelberg Pharma Company Details
Table 109. Heidelberg Pharma Business Overview
Table 110. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product
Table 111. Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 112. Heidelberg Pharma Recent Developments
Table 113. Mersana Therapeutics Company Details
Table 114. Mersana Therapeutics Business Overview
Table 115. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 116. Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 117. Mersana Therapeutics Recent Developments
Table 118. Astellas Pharma/Agensys Company Details
Table 119. Astellas Pharma/Agensys Business Overview
Table 120. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product
Table 121. Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 122. Astellas Pharma/Agensys Recent Developments
Table 123. AbbVie Inc Company Details
Table 124. AbbVie Inc Business Overview
Table 125. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product
Table 126. AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 127. AbbVie Inc Recent Developments
Table 128. Celldex Therapeutics Company Details
Table 129. Celldex Therapeutics Business Overview
Table 130. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 131. Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 132. Celldex Therapeutics Recent Developments
Table 133. Immunomedics Company Details
Table 134. Immunomedics Business Overview
Table 135. Immunomedics Antibody Drug Conjugate (ADC) Drug Product
Table 136. Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 137. Immunomedics Recent Developments
Table 138. Agensys Company Details
Table 139. Agensys Business Overview
Table 140. Agensys Antibody Drug Conjugate (ADC) Drug Product
Table 141. Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 142. Agensys Recent Developments
Table 143. Genentech Company Details
Table 144. Genentech Business Overview
Table 145. Genentech Antibody Drug Conjugate (ADC) Drug Product
Table 146. Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 147. Genentech Recent Developments
Table 148. ImmunoGen Company Details
Table 149. ImmunoGen Business Overview
Table 150. ImmunoGen Antibody Drug Conjugate (ADC) Drug Product
Table 151. ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 152. ImmunoGen Recent Developments
Table 153. Sanofi Company Details
Table 154. Sanofi Business Overview
Table 155. Sanofi Antibody Drug Conjugate (ADC) Drug Product
Table 156. Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 157. Sanofi Recent Developments
Table 158. Genmab Company Details
Table 159. Genmab Business Overview
Table 160. Genmab Antibody Drug Conjugate (ADC) Drug Product
Table 161. Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 162. Genmab Recent Developments
Table 163. Amgen Company Details
Table 164. Amgen Business Overview
Table 165. Amgen Antibody Drug Conjugate (ADC) Drug Product
Table 166. Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 167. Amgen Recent Developments
Table 168. Novartis Company Details
Table 169. Novartis Business Overview
Table 170. Novartis Antibody Drug Conjugate (ADC) Drug Product
Table 171. Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 172. Novartis Recent Developments
Table 173. Eli Lilly Company Details
Table 174. Eli Lilly Business Overview
Table 175. Eli Lilly Antibody Drug Conjugate (ADC) Drug Product
Table 176. Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 177. Eli Lilly Recent Developments
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Drug Conjugate (ADC) Drug Market Share by Type: 2021 VS 2028
Figure 2. Mmunomedics Technology Features
Figure 3. Immunogen Technology Features
Figure 4. Seattle Genetics Technology Features
Figure 5. Others Features
Figure 6. Global Antibody Drug Conjugate (ADC) Drug Market Share by Application: 2021 VS 2028
Figure 7. Biotechnology Companies Case Studies
Figure 8. Specialized Cancer Centers Case Studies
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Academic Research Institutes Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 14. Global Antibody Drug Conjugate (ADC) Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Antibody Drug Conjugate (ADC) Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Antibody Drug Conjugate (ADC) Drug Market Share by Region: 2021 VS 2028
Figure 17. Global Antibody Drug Conjugate (ADC) Drug Market Share by Players in 2021
Figure 18. Global Top Antibody Drug Conjugate (ADC) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate (ADC) Drug as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Antibody Drug Conjugate (ADC) Drug Revenue in 2021
Figure 20. North America Antibody Drug Conjugate (ADC) Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2028)
Figure 22. North America Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2028)
Figure 23. North America Antibody Drug Conjugate (ADC) Drug Market Size Share by Country (2017-2028)
Figure 24. United States Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Antibody Drug Conjugate (ADC) Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2028)
Figure 28. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2028)
Figure 29. Europe Antibody Drug Conjugate (ADC) Drug Market Size Share by Country (2017-2028)
Figure 30. Germany Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size Share by Region (2017-2028)
Figure 40. China Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Antibody Drug Conjugate (ADC) Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Antibody Drug Conjugate (ADC) Drug Market Size Share by Country (2017-2028)
Figure 50. Mexico Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size Share by Country (2017-2028)
Figure 56. Turkey Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Oxford Bio Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 60. Synthon Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 61. Progenics Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 62. Bayer HealthCare Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 63. Millennium Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 64. Pfizer Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 65. Concortis Bio therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 66. Roche Holding AG Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 67. Seattle Genetics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 68. Heidelberg Pharma Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 69. Mersana Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 70. Astellas Pharma/Agensys Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 71. AbbVie Inc Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 72. Celldex Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 73. Immunomedics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 74. Agensys Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 75. Genentech Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 76. ImmunoGen Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 77. Sanofi Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 78. Genmab Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 79. Amgen Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 80. Novartis Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 81. Eli Lilly Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Industry Market Size
